First phase trial of Covaxin, India’s Covid-19 vaccine, star
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
Bharat Biotech International Limited (BBIL), which developed India’s first potential indigenous Covid vaccine, has said the first phase of testing has begun on 375 people, according to a report on 18 July.

• Bharat Biotech has said that human trials of Covaxin started on July 15.

• The vaccine manufacturer has said that these are randomised double-blind clinical trials.

• Human trials of Covaxin have begun at the All India Institute of Medical Sciences, Patna. AIIMS-Patna chose 10 volunteers to start the human trial of Covaxin.

• According to several reports, the first dose of the vaccine has been administered to the study participants. They will be given the second dose after an interval of 14 days.

• ICMR has selected 12 institutes to conduct these trials, including AIIMS in Delhi and Patna.

• Covaxin will be tested on over 1,100 people in two phases. Bharat Biotech has planned to enroll 375 people in the first phase of clinical trials.

• Depending on the results of the first trial, the company has a plan to enroll 750 people in the second phase of trial.

a●●●●h g●●●a and 41 others like this8 shares
Dr. R●●●●●●●●r G●●●●i
Dr. R●●●●●●●●r G●●●●i pediatrics
Congratulations best of luck for bright future go ahead GOOD always with us
Jul 18, 2020Like
Dr. S S M●●●●●●m
Dr. S S M●●●●●●m Internal Medicine
Congrats.Hope all goes right with God' s help.
Jul 19, 2020Like
Dr. DR H●●. C●●●●●●●●●●I H●●●●●I
Dr. DR H●●. C●●●●●●●●●●I H●●●●●I Internal Medicine
Releable & informative video let' s hope for the best
Jul 19, 2020Like